Dexamethasone eye drops containing γ-cyclodextrin-based nanogels.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsMoya-Ortega, Maria D
Alves, Tiago F G
MetadataShow full item record
CitationInt J Pharm 2013, 441(1-2):507-15
AbstractSustained release aqueous eye drops of dexamethasone, based on cyclodextrin (CD) nanogels, were designed and tested in vivo. γCD units were cross-linked in the form of nanogels by means of an emulsification/solvent evaporation process. The composition of the nanogels was optimized with regard to drug loading and release rate. The eye drops consisted of an aqueous solution of dexamethasone in 2-hydroxypropyl-γ-cyclodextrin (HPγCD) medium containing γCD nanogels. The nanogel eye drops (containing 25 mg dexamethasone per ml) were tested in rabbits and compared to the commercially available product Maxidex(®) (suspension with 1 mg dexamethasone per ml). One drop administration of the nanogel eye drops resulted in nearly constant dexamethasone concentration for at least 6h in the tear fluid (mean concentration±SD=295±59 μg/ml) whereas the concentration after administration of Maxidex(®) fell rapidly from 9.72±3.45 μg/ml 1 h after application to 3.76±3.26 μg/ml 3 h after application. The maximum dexamethasone concentration in the aqueous humor (2 h after application) was 136±24 mg/ml after application of the nanogel eye drops, and only 44.4±7.8 μg/ml after application of Maxidex(®). The dexamethasone nanogel eye drops were well tolerated with no macroscopic signs of irritation, redness or other toxic effects.
DescriptionTo access publisher's full text version of this article. Please click on the hyperlink in Additional Links field.
RightsArchived with thanks to International journal of pharmaceutics
- Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans.
- Authors: Kristinsson JK, Fridriksdóttir H, Thórisdóttir S, Sigurdardóttir AM, Stefánsson E, Loftsson T
- Issue date: 1996 May
- Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops.
- Authors: Loftsson T, Hreinsdóttir D, Stefánsson E
- Issue date: 2007 May
- Kinetics of γ-cyclodextrin nanoparticle suspension eye drops in tear fluid.
- Authors: Jóhannesson G, Moya-Ortega MD, Ásgrímsdóttir GM, Lund SH, Thorsteinsdóttir M, Loftsson T, Stefánsson E
- Issue date: 2014 Sep
- yCD/HPyCD mixtures as solubilizer: solid-state characterization and sample dexamethasone eye drop suspension.
- Authors: Jansook P, Ritthidej GC, Ueda H, Stefánsson E, Loftsson T
- Issue date: 2010
- Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations.
- Authors: Jóhannsdóttir S, Jansook P, Stefánsson E, Loftsson T
- Issue date: 2015 Sep 30